Versuchen GOLD - Frei
“Pursue ‘1-10-60 rule' to effectively combat sophisticated cyber-threats”
BioSpectrum Asia
|May 2020
As hospitals and medical organisations around the world are working endlessly to preserve the wellbeing of individuals stricken with COVID-19, cybercrime hackers are silently targeting hospitals to exploiting stretched healthcare resources and to access critical care systems through cyber-attacks.

Interpol, the international police organisation has issued an alert following a rise in ransomware attacks on hospitals and other healthcare institutions amidst the pandemic. Most alarmingly, in late-March, a medical facility on standby to help test any coronavirus vaccine has been hit by a ransomware group. Similarly, hackers have been posing as government entities in India, Japan, Singapore and even the World Health Organisation (WHO) to send bogus health advisories on coronavirus through email, infecting people with malware. Malaysia reported spike in cybersecurity cases by a whopping 82.5 percent during the COVID-19 Movement Control Order so far. In a recent conversation with BioSpectrum Asia, Sherif El-Nabawi, Vice President (Engineering, APJ), CrowdStrike, Singapore gave insight on healthcare cyber-attacks and keys to mitigate the risk. Edited excerpts;
How do cyber-attackers exploit healthcare resources during the COVID-19 pandemic and what are the consequences of cyber-attacks on Asia-Pacific healthcare sector?
The world has witnessed the COVID-19 pandemic place unprecedented strain on many countries’ healthcare systems. It has been the catalyst for a paradigm shiftin the way organisations operate, with many having to move quickly to stand-up a remote workforce or enable remote doctor consultations due to social distancing guidelines. This has created a perfect storm for adversaries to launch targeted attacks against an overstretched healthcare industry.
Threat activity has ranged from financially motivated threat actors targeting hospitals to deny them access to critical systems and disrupting their ability to provide patient care, to the compromise of sensitive patient information.
Diese Geschichte stammt aus der May 2020-Ausgabe von BioSpectrum Asia.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON BioSpectrum Asia

BioSpectrum Asia
Collaborative R&D: Partnerships shaping the future of biopharma
Biotechs and pharma companies face rising costs of drug development, depleting R&D pipelines and diminishing returns on investment. By joining forces and exploring collaborative R&D partnerships it is possible to overcome these challenges. In addition to sharing risks, they share the potential rewards when their assets move further into clinical development or come to the market.
2 mins
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Quantum Computing: Future of diagnostics is being coded today
A silent revolution is being built at the intersection of biology and quantum physics. After decades of pushing the boundaries of diagnostics with advanced imaging and AI, we are now approaching a hard computational wall. For complex conditions like Alzheimer's, Parkinson's, and many cancers, the interacting variables of genomics, proteomics, and real-world patient data are simply too vast for classical computers to master. This limitation caps the ability to move from merely spotting correlations to uncovering true causation. Unlike traditional AI, quantum computing can simulate underlying physical systems to derive precise solutions. The transition from correlational analysis to causal simulation will enable a more valuable and advanced frontier in diagnostics.
4 mins
BioSpectrum Asia Sep 2025
BioSpectrum Asia
First Pacific woman to serve as public health director in NZ
The Ministry of Health in New Zealand (NZ) has appointed Dr Corina Grey as the new Director of Public Health this year, a landmark appointment for Pacific leadership.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Bio-Rad appoints Rajat Mehta as Executive Vice President of Global Commercial Operations
Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, has announced the appointment of Rajat Mehta as its new Executive Vice President, Global Commercial Operations, effective August 4, 2025.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Hugel launches botulinum toxin Letybo in Malaysia
South Korea-based Hugel Inc., a leading global medical aesthetics company, has officially launched its botulinum toxin product Letybo in Malaysia - an emerging market for medical aesthetics in Southeast Asia.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Australia designs smart wound monitor to improve chronic infection care
Researchers from Australia's RMIT University have developed a wearable wound monitoring device with integrated sensors that could reduce infection risks by minimising the need for frequent physical contact.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Revvity unveils innovative reagent technology to accelerate therapeutics development
US-based Revvity, Inc. has announced the launch of pHSense reagents, a powerful technology designed to advance internalisation studies in drug discovery.
1 min
BioSpectrum Asia Sep 2025

BioSpectrum Asia
Sanofi acquires next-gen vaccine biotech Vicebio for $1.6 B
Vicebio, a biopharmaceutical company with operations in Australia, UK and Belgium, has entered an exclusive, definitive agreement to be acquired by Sanofi.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
HOSMAC signs MoU with Gulf Medical University to strengthen healthcare education
HOSMAC, Asia's leading hospital planning, design, and management consultancy, has signed a Memorandum of Understanding (MoU) with Gulf Medical University (GMU), Ajman, UAE, to serve as an industry partner.
1 min
BioSpectrum Asia Sep 2025
BioSpectrum Asia
Jessica Cowden takes charge as Deputy Director General of CARE unit at IVI
Dr Jessica Cowden has been appointed Deputy Director General of the Clinical, Assessment, Regulatory, Evaluation (CARE) unit at South Korea-headquartered International Vaccine Institute (IVI). She will continue to be based at IVI's Europe Regional Office in Stockholm, Sweden.
1 min
BioSpectrum Asia Sep 2025
Translate
Change font size